Support CleanTechnica’s work through a Substack subscription or on Stripe. One of the big automotive stories out of CES 2026 from the last week was Ford making an announcement about eyes-free driving coming to its models — affordable EVs even — in 2028. There are layers to this, though. Ford’s L3 Eyes-Off Driving Plans —… Continue reading Clean Technica: Ford, Waymo, Tesla — Where Is Self-Driving Going in 2026?004321
Tag: Mobility
iQOO 15 Debuts Samsung 2K M14 LEAD™ OLED Display to Lead the Next Generation of Flagship Visuals
DONGGUAN, China, Jan. 12, 2026 /PRNewswire/ — After more than two years of joint development with Samsung, iQOO brings the Samsung 2K M14 LEAD™ OLED Display to the world on its latest flagship, iQOO 15. As a display to combine the all-new M14 light-emitting material with next-generation 2K LEAD OLED technology, Samsung 2K M14 LEAD™ OLED Display delivers… Continue reading iQOO 15 Debuts Samsung 2K M14 LEAD™ OLED Display to Lead the Next Generation of Flagship Visuals
AISpeech’s Smart Mobility Solutions Debut at CES 2026
LAS VEGAS, Jan. 12, 2026 /PRNewswire/ — At CES 2026 in Las Vegas, The article is from Shuzhi Society: AISpeech, a leading conversational AI platform provider, presented its latest breakthroughs in the intelligent mobility sector. With a focus on end-to-end conversational AI, AISpeech showcased the strength and innovation of China’s AI technology on a global… Continue reading AISpeech’s Smart Mobility Solutions Debut at CES 2026
New Proposed Legislation Would Let Self-Driving Cars Operate in New York State
As self-driving car services from Alphabet’s Waymo, Amazon’s Zoox, and Tesla have slowly, quietly expanded across the US, one big, important state has mostly stayed mum: New York. The union’s fourth most populous state has some of the tightest laws governing autonomous vehicles, requiring companies approved to test in the state to only do so… Continue reading New Proposed Legislation Would Let Self-Driving Cars Operate in New York State
FBI Agent’s Sworn Testimony Contradicts Claims ICE’s Jonathan Ross Made Under Oath
In testimony last month in federal court in Minnesota, FBI special agent Bernardo Medellin appeared to directly contradict a claim that ICE agent Jonathan Ross made under oath about whether a man they were trying to detain had asked to speak to his attorney. Medellin’s testimony, which details federal training for interactions with drivers, also… Continue reading FBI Agent’s Sworn Testimony Contradicts Claims ICE’s Jonathan Ross Made Under Oath
Platform Ecosystems in Digital Entertainment: How NEKO77 Shapes the Future of Interactive Media
Digital entertainment has entered a new phase driven not only by content, but by the ecosystems that enable it. Platform ecosystems are becoming critical infrastructures where technology, community behavior, governance models, and business models converge. In this landscape, ecosystem-oriented platforms such as NEKO77 demonstrate how interoperability, trust, and user-centric design are redefining the future of… Continue reading Platform Ecosystems in Digital Entertainment: How NEKO77 Shapes the Future of Interactive Media
German Handelsblatt: Autotest: With the ID. Polo, VW wants to build a Volkswagen again012191
Things haven’t been going well at VW lately. The people of Lower Saxony not only failed to get started with e-mobility, but also ignored the wishes of their customers. This should get better now. Go to Source
Abbisko Therapeutics Announces FDA Acceptance of the NDA for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor
SHANGHAI, Jan. 12, 2026 /PRNewswire/ — 13 January 2026 (Beijing Time), Abbisko Therapeutics Co., Ltd. (“Abbisko Therapeutics” hereafter, HKEX code: 02256.HK) announced today that the New Drug Application (NDA) for its novel, orally administered, highly selective, and potent small-molecule colony-stimulating factor 1 receptor (CSF-1R) inhibitor, pimicotinib (ABSK021), for the systemic treatment of patients with tenosynovial… Continue reading Abbisko Therapeutics Announces FDA Acceptance of the NDA for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor
ZWHAND Shines at CES 2026: Redefining Robotic Hands for Mass Embodied AI
LAS VEGAS, Jan. 12, 2026 /PRNewswire/ — CES 2026 launched with embodied AI commercialization as its core focus. Following humanoid robots’ mass production debut in 2025, dexterous hands have become critical for human-robot interaction, directly determining robots’ real-world value. ZWHAND stole the spotlight with its “high-precision, mass-producible” robotic hand lineup, making a highly anticipated global… Continue reading ZWHAND Shines at CES 2026: Redefining Robotic Hands for Mass Embodied AI
NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery
News Summary: Lilly and NVIDIA launch AI co-innovation lab to tackle drug discovery challenges. NVIDIA collaborates with Thermo Fisher to build autonomous lab infrastructure for scalable scientific discovery. Chai Discovery, Basecamp Research, Boltz and ecosystem leaders connect NVIDIA BioNeMo, agentic AI and physical AI to scale science and drug discovery. J.P. Morgan Healthcare Conference—NVIDIA today… Continue reading NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery